Advanced search
Publication Cover
Clinical Epidemiology Volume 16, 2024 - Issue
Submit an article Journal homepage
92
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

Author Response to Letter to the Editor regarding “the Epidemiology of Bile Acid Diarrhea in Denmark” [Response to Letter]

Anne-Marie Ellegaard1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4389-3908
ORCID Icon,
Martin L Kårhus1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, DenmarkORCID Iconhttps://orcid.org/0000-0002-3842-1287
ORCID Icon,
Filip K Knop1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, Denmark;2 Steno Diabetes Center Copenhagen, Herlev, Denmark;3 Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-2495-5034
ORCID Icon &
Line L Kårhus4 Center for Clinical Research and Prevention, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Frederiksberg, DenmarkORCID Iconhttps://orcid.org/0000-0002-1722-8269
ORCID Icon
Pages 5-6 | Received 15 Dec 2023, Accepted 03 Jan 2024, Published online: 16 Jan 2024

References

  • Kårhus ML, Ellegaard AM, Winther-Jensen M, Hansen S, Knop FK, Kårhus LL. The epidemiology of bile acid diarrhea in Denmark. Clin Epidemiol. 2023;15:1173–1181. doi:10.2147/CLEP.S442054
  • Kårhus ML, Brønden A, Lyng Forman J, et al. Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption. BMJ Open. 2021;11(2):e044711. doi:10.1136/bmjopen-2020-044711
  • Kårhus ML, Brønden A, Forman JL, et al. Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. Lancet Gastroenterol Hepatol. 2022;7(10):922–931. doi:10.1016/S2468-1253(22)00198-4

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.